Skip to main content
GC CELL CORPORATION logo

GC CELL CORPORATION — Investor Relations & Filings

Ticker · 144510 ISIN · KR7144510005 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2025-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 144510

About GC CELL CORPORATION

http://gccell.com/en/main.do

GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for GC Cell, covering the fiscal year 2024. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. It is not an Annual Report (10-K) as it lacks the management discussion and analysis (MD&A) and business overview sections typical of a full 10-K, focusing specifically on the audit and financial statements. FY 2024
2025-03-17 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GC Cell. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on financial statements, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow, etc.) as part of the meeting materials provided to shareholders. According to the filing definitions, materials shared during or for an Annual General Meeting are classified as AGM-R.
2025-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and financial statements for the fiscal year. This document is a formal proxy solicitation material sent to shareholders to request their votes for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-10 Korean
주주총회소집결의 (정기주주총회)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by GC Cell. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2025-02-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a significant change in financial performance (revenue or profit/loss structure exceeding 15% for large corporations or 30% for others). It provides preliminary financial results, including revenue, operating profit, and net income, along with the reasons for the change. This is a standard 'Earnings Release' (ER) filing, as it provides the initial announcement of financial results before the final audited annual report is published. FY 2024
2025-01-24 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and the closure of the shareholder register for the purpose of holding an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notification of the administrative process for shareholder identification. Given it is a standard regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2024-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.